Header Logo

Connection

ANITA DESWAL to Neoplasms

Back to Details
This is a "connection" page, showing publications ANITA DESWAL has written about Neoplasms.
ANITA DESWAL
Connection Strength
2.907
Neoplasms
  1. Safety of Contemporary Radiation Therapy in Patients With Cardiac Implantable Electronic Devices: Implications for Clinical Practice. J Am Heart Assoc. 2025 Sep 02; 14(17):e042937.
    View in: PubMed
    Score: 0.323
  2. Cardiovascular toxicity of immune therapies for cancer. BMJ. 2024 05 15; 385:e075859.
    View in: PubMed
    Score: 0.296
  3. Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin. 2022 Jul; 18(3):361-374.
    View in: PubMed
    Score: 0.260
  4. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep. 2020 10 10; 22(12):171.
    View in: PubMed
    Score: 0.230
  5. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc. 2020 01 21; 9(2):e013757.
    View in: PubMed
    Score: 0.219
  6. Incident cancer in patients with heart failure: causation or mere association? J Am Coll Cardiol. 2013 Sep 03; 62(10):887-8.
    View in: PubMed
    Score: 0.139
  7. Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers. Cancer Med. 2026 Apr; 15(4):e71682.
    View in: PubMed
    Score: 0.084
  8. Cardiovascular Outcomes in Patients With Cancer Undergoing Cardiac Implantable Electronic Device Implantation. Pacing Clin Electrophysiol. 2025 11; 48(11):1309-1319.
    View in: PubMed
    Score: 0.081
  9. Tackling the Cardio-Kidney-Metabolic Burden in Cancer. Curr Atheroscler Rep. 2025 Sep 15; 27(1):92.
    View in: PubMed
    Score: 0.081
  10. Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025 Nov; 27(11):2152-2167.
    View in: PubMed
    Score: 0.081
  11. Impacts of Radiation on Metabolism and Vascular Cell Senescence. Antioxid Redox Signal. 2025 07; 43(1-3):92-114.
    View in: PubMed
    Score: 0.079
  12. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol. 2025 03; 45(3):372-385.
    View in: PubMed
    Score: 0.077
  13. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025 02; 31(2):415-455.
    View in: PubMed
    Score: 0.076
  14. Moving theory and reality closer together in cardio-oncology training. Eur J Heart Fail. 2024 Apr; 26(4):772-775.
    View in: PubMed
    Score: 0.073
  15. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure. Cardiovasc Drugs Ther. 2025 06; 39(3):553-562.
    View in: PubMed
    Score: 0.072
  16. SGLT2 Inhibitor Use and Risk of Clinical?Events in Patients With Cancer Therapy-Related Cardiac Dysfunction. JACC Heart Fail. 2024 01; 12(1):67-78.
    View in: PubMed
    Score: 0.071
  17. Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.
    View in: PubMed
    Score: 0.071
  18. Kinase Inhibitors and Atrial Fibrillation: Mechanisms of Action and Clinical Implications. JACC Clin Electrophysiol. 2023 04; 9(4):591-602.
    View in: PubMed
    Score: 0.068
  19. Advances in Multimodality Imaging in?Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 10 18; 80(16):1560-1578.
    View in: PubMed
    Score: 0.066
  20. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer? Curr Atheroscler Rep. 2022 08; 24(8):599-606.
    View in: PubMed
    Score: 0.064
  21. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
    View in: PubMed
    Score: 0.064
  22. Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep. 2022 05; 24(5):543-553.
    View in: PubMed
    Score: 0.063
  23. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst. 2021 05 04; 113(5):513-522.
    View in: PubMed
    Score: 0.060
  24. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol. 2021 05; 73(5):866-874.
    View in: PubMed
    Score: 0.060
  25. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy. 2020; 65(3-4):65-76.
    View in: PubMed
    Score: 0.058
  26. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol. 2020 08 15; 313:1-8.
    View in: PubMed
    Score: 0.056
  27. Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunol Res. 2024 Aug 01; 12(8):964-987.
    View in: PubMed
    Score: 0.019
  28. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart. 2021 12; 8(2).
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.